437 related articles for article (PubMed ID: 16882706)
1. Suppression of hepcidin during anemia requires erythropoietic activity.
Pak M; Lopez MA; Gabayan V; Ganz T; Rivera S
Blood; 2006 Dec; 108(12):3730-5. PubMed ID: 16882706
[TBL] [Abstract][Full Text] [Related]
2. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.
Piperno A; Galimberti S; Mariani R; Pelucchi S; Ravasi G; Lombardi C; Bilo G; Revera M; Giuliano A; Faini A; Mainini V; Westerman M; Ganz T; Valsecchi MG; Mancia G; Parati G;
Blood; 2011 Mar; 117(10):2953-9. PubMed ID: 21149632
[TBL] [Abstract][Full Text] [Related]
3. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.
Vokurka M; Krijt J; Sulc K; Necas E
Physiol Res; 2006; 55(6):667-674. PubMed ID: 16497104
[TBL] [Abstract][Full Text] [Related]
4. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli.
Huang H; Constante M; Layoun A; Santos MM
Blood; 2009 Apr; 113(15):3593-9. PubMed ID: 19204324
[TBL] [Abstract][Full Text] [Related]
5. Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.
Matsumoto M; Tsujino T; Lee-Kawabata M; Naito Y; Akahori H; Sakoda T; Ohyanagi M; Tomosugi N; Masuyama T
Circ J; 2010 Feb; 74(2):301-6. PubMed ID: 20019408
[TBL] [Abstract][Full Text] [Related]
6. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.
Mastrogiannaki M; Matak P; Mathieu JR; Delga S; Mayeux P; Vaulont S; Peyssonnaux C
Haematologica; 2012 Jun; 97(6):827-34. PubMed ID: 22207682
[TBL] [Abstract][Full Text] [Related]
7. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.
Liu Q; Davidoff O; Niss K; Haase VH
J Clin Invest; 2012 Dec; 122(12):4635-44. PubMed ID: 23114598
[TBL] [Abstract][Full Text] [Related]
9. Regulation of hepcidin expression at high altitude.
Talbot NP; Lakhal S; Smith TG; Privat C; Nickol AH; Rivera-Ch M; León-Velarde F; Dorrington KL; Mole DR; Robbins PA
Blood; 2012 Jan; 119(3):857-60. PubMed ID: 22130801
[TBL] [Abstract][Full Text] [Related]
10. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia.
Lasocki S; Millot S; Andrieu V; Lettéron P; Pilard N; Muzeau F; Thibaudeau O; Montravers P; Beaumont C
Crit Care Med; 2008 Aug; 36(8):2388-94. PubMed ID: 18664788
[TBL] [Abstract][Full Text] [Related]
11. Regulation of systemic iron homeostasis.
Finberg KE
Curr Opin Hematol; 2013 May; 20(3):208-14. PubMed ID: 23426198
[TBL] [Abstract][Full Text] [Related]
12. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
Theurl M; Nairz M; Schroll A; Sonnweber T; Asshoff M; Haschka D; Seifert M; Willenbacher W; Wilflingseder D; Posch W; Murphy AT; Witcher DR; Theurl I; Weiss G
Haematologica; 2014 Sep; 99(9):1516-24. PubMed ID: 24895335
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations.
Dallalio G; Law E; Means RT
Blood; 2006 Apr; 107(7):2702-4. PubMed ID: 16332970
[TBL] [Abstract][Full Text] [Related]
15. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin: clinical utility as a diagnostic tool and therapeutic target.
Coyne DW
Kidney Int; 2011 Aug; 80(3):240-4. PubMed ID: 21677632
[TBL] [Abstract][Full Text] [Related]
17. Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice.
Sasaki Y; Noguchi-Sasaki M; Matsuo-Tezuka Y; Matsumoto-Omori Y; Kurasawa M; Yorozu K; Shimonaka Y
Int J Hematol; 2014; 99(5):561-9. PubMed ID: 24623262
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin.
Ganz T
Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.
Roy CN; Mak HH; Akpan I; Losyev G; Zurakowski D; Andrews NC
Blood; 2007 May; 109(9):4038-44. PubMed ID: 17218383
[TBL] [Abstract][Full Text] [Related]
20. RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice.
Langdon JM; Barkataki S; Berger AE; Cheadle C; Xue QL; Sung V; Roy CN
Am J Hematol; 2015 Jan; 90(1):8-14. PubMed ID: 25236856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
